The Real Fake-Drug Danger
Letter to the Editor

In his May 13 letter responding to my op-ed ("China's Bad Medicine," May 5), Peter Maybarduk obfuscates the definition of fake drugs. Illegally copying a trademark is an important indicator of counterfeiting, although not necessarily of substandard drug quality. It is not safe to assume that a drug being passed off as a brand will work the same as the brand, so trademark breaches are important warning flags for public health.

Real generics, the biological effects of which are proven to be the same as branded originals, should not be conflated with substandard products. But many of the products found in the poorest countries are neither brands nor generics--they are copy products of indeterminate quality.

For example, a 2008 World Health Organization report found fewer than 43% of the 187 antimalarial products on sale in Kenya were registered there and about 16% failed quality tests. India and China supplied 24% of the drugs, most of which were not registered in Kenya. Some of those drugs were probably of good quality, but some definitely weren't.

If China and India do not improve their own oversight of their producers, including using simple tools like assessing trademarks, then more people will continue to die needlessly.

Roger Bate is the Legatum Fellow in Global Prosperity at the AEI.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate

What's new on AEI

To secure southern border, US must lead international effort to stabilize Central America
image The Ryan pro-work, anti-poverty plan: Thomas Aquinas 1, Ayn Rand 0
image Does SNAP support work? Yes and no
image Obama Democrats lose their big bet on health exchanges
AEI on Facebook
Events Calendar
  • 28
    MON
  • 29
    TUE
  • 30
    WED
  • 31
    THU
  • 01
    FRI
Tuesday, July 29, 2014 | 10:00 a.m. – 12:00 p.m.
Is Medicare’s future secure? The 2014 Trustees Report

Please join AEI as the chief actuary for Medicare summarizes the report’s results, followed by a panel discussion of what those spending trends are likely to mean for seniors, taxpayers, the health industry, and federal policy.

Friday, August 01, 2014 | 10:30 a.m. – 12:00 p.m.
Watergate revisited: The reforms and the reality, 40 years later

Please join us as four of Washington’s most distinguished political observers will revisit the Watergate hearings and discuss reforms that followed.

No events scheduled this day.
No events scheduled today.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.